Cargando…
RNA-based therapeutics for neurological diseases
RNA-based therapeutics have entered the mainstream with seemingly limitless possibilities to treat all categories of neurological disease. Here, common RNA-based drug modalities such as antisense oligonucleotides, small interfering RNAs, RNA aptamers, RNA-based vaccines and mRNA drugs are reviewed h...
Autor principal: | Anthony, Karen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786337/ https://www.ncbi.nlm.nih.gov/pubmed/35067193 http://dx.doi.org/10.1080/15476286.2021.2021650 |
Ejemplares similares
-
Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases
por: Holm, Anja, et al.
Publicado: (2022) -
Human Endogenous Retrovirus as Therapeutic Targets in Neurologic Disease
por: Giménez-Orenga, Karen, et al.
Publicado: (2021) -
Principles of Therapeutic Apheresis in Neurological Disease
por: Strasser, Erwin
Publicado: (2023) -
Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases
por: Yeo, Xin Yi, et al.
Publicado: (2022) -
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
por: Liu, Jinsha, et al.
Publicado: (2021)